4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010205
Options or other derivatives
- Director acquired 96,590 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
RECTOR DAVID · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-02-19 | Grant or award : show line 1 in the form Common Stock Options | +96,590 | $0.13 | 2023-02-19 | 96,590 | 1,460,579 | D |
Loading xslF345X03/form457958_20130220030120-.xml…